The effect of a continuous low dose progestin on tubal and uterine motility.

In: International journal of fertility · 1973 · vol. 18(3) , pp. 161–6 · PMID:4357281 · W2288774169
article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-08-05

This study found that daily megestrol acetate partially suppressed tubal motility and altered uterine motility patterns, leading to less pronounced cyclic changes and potential impairment of estrogen-dependent isthmic closure.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The pattern of tubal and uterine motility was investigated in 16 women treated with 350 mcs megestrol acetate daily for 4 weeks. Myometrial activity characteristic of estrogen domination was recorded during the proliferative phase in most patients during the treatment cycle. A pattern of luteal domination was also recorded in most patients during the third week of the cycle but in some cases the pattern of uterine motility was considered atypical for the phase of the cycle and suggestive of insufficient progesterone secretion. In 1/2 the patients tubal motility was depressed during the treatment but a moderate degree of motility was retained by the tube at all times. The cyclic changes that occur in tubal motility during the normal ovulatory cycles were less pronounced or lacking in the treated patients. It is proposed that the estrogen dependent isthmic closure which occurs during the ovulatory period is impaired in the patients treated with megestrol acetate.(Authors modified)

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK